COMMUNITY PROFILE

Abbas is a Non-executive Director at Immunocore Ltd, the world's leading TCR company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases. 

Until recently, Abbas was President, Global Pharmaceuticals, at GSK, a role he held from October 2014. He was accountable for the company’s global commercial Pharmaceuticals business and was a member of the Corporate Executive Team. He had joined the company as President, Emerging Markets & Asia Pacific in June 2008.

Abbas was appointed to the ViiV Healthcare board in October 2009 and the Aspen board in December 2009. He was also a member of GSK's Audit & Risk Committee from January 2012.
 
Before GSK, he was President, Europe at Eli Lilly. He was also Vice President, Europe with specific responsibility for the Western European mid-size countries, Africa & Middle East Area/Commonwealth of Independent States and Central & Eastern Europe regions.
 
Abbas joined Lilly UK in 1988 as Sales Representative GP & Hospital Sales East London. He then moved to Australia in 1990, where he became Associate of Market Research & New Product Planning and subsequently District Sales Manager.